Evidence map›Paper›PMID 39139393›Full record

ArticleGenes & diseases2024

Precise and efficient insertion of A673T mutation in APP gene using MSYM.

Qing Xia, Zijie Liu, Xinyu Yang, Jiaying Xiao, Xue Zhao, Yu Zhao, Feifei Zheng, Fangliang Ge, Ke Ye, Lulu Liu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes & diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qing XiaDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Zijie LiuDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Xinyu YangDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Jiaying XiaoDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Xue ZhaoDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Yu ZhaoDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Feifei ZhengDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Fangliang GeDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Ke YeDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Lulu LiuDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Dayong WangDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.
Xu GaoDepartment of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang 150000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39139393
PMCPMC11320440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.